Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCP (clone D0Z9Q). We employs the Lentivirus (trc-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Single base pair Base Editing/Positive feedback for a robust and sustained response against cancers.
Host
human
Target
CCP
Clone
D0Z9Q
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
trc
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Base Editing
Modification Domain
Single base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.91
Cell Culture
3D Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.